Exact Mass: 483.1464
Exact Mass Matches: 483.1464
Found 261 metabolites which its exact mass value is equals to given mass value 483.1464
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nicergoline
Nicergoline is only found in individuals that have used or taken this drug. It is an ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It has been suggested to ameliorate cognitive deficits in cerebrovascular disease. [PubChem]Nicergoline acts by inhibiting the postsynaptic alpha(1)-adrenoceptors on vascular smooth muscle. This inhibits the vasoconstrictor effect of circulating and locally released catecholamines (epinephrine and norepinephrine), resulting in peripheral vasodilation. Therefore the mechanism of Nicergoline is to increase vascular circulation in the brain, thereby enhancing the transmission of nerve signals across the nerve fibres, which secrete acetylcholine as a neural transmitter. C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AE - Ergot alkaloids C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Nicergoline, an ergoline derivative ester of bromonicotinic acid, is a potent, selective and orally active antagonist of α1A-adrenoceptor. Nicergoline has vasodilator effects. Nicergoline also has ameliorative effects on cognitive function in mouse models of Alzheimer's disease[1][2].
O-Ethyl-4-[(2',3',4'-tri-O-acetyl-alpha-L-rhamnosyloxy)benzyl]thiocarbamate
O-Ethyl-4-[(2,3,4-tri-O-acetyl-alpha-L-rhamnosyloxy)benzyl]thiocarbamate is a fully acetylated thiocarbamate glycoside. It has been isolated from the leaves of Moringa oleifera (horseradish tree). It is found in fats and oils, herbs and spices, and green vegetables. Constituent of Moringa oleifera (horseradish tree) (Moringaceae). N-[(4-hydroxyphenyl)methyl]ethoxycarbothioamide 4-(tri-acetylrhamnoside) is found in fats and oils, herbs and spices, and green vegetables.
Avanafil
Baloxavir
(E)-(4R,9As)-7-[3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene]-4-(3,4,5-trifluorophenyl)hexahydropyrido[2,1-c][1,4]oxazin-6-one
2-[2-[Bis(carboxymethyl)amino]ethyl-[2-[bis(carboxymethyl)amino]-3-phenylpropyl]amino]acetic acid
(S)-4-((3-Chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
(+/-)-1,3-dihydroxy-2-<1-(7-methoxy-2-oxo-2H-chromen-6-yl)-3-methyl-2-butenyl>-10-methyl-9-acridone|acrimarine-M
N-Ac-13-[(2-Amino-2-carboxyethyl)thio]-14-hydroxy-4,7,9,11-octadecatetraenedioic acid
N-[(4-hydroxyphenyl)methyl]ethoxycarbothioamide 4-(tri-acetylrhamnoside)
Nicergoline
C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AE - Ergot alkaloids C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 0.982 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.978 Nicergoline, an ergoline derivative ester of bromonicotinic acid, is a potent, selective and orally active antagonist of α1A-adrenoceptor. Nicergoline has vasodilator effects. Nicergoline also has ameliorative effects on cognitive function in mouse models of Alzheimer's disease[1][2].
Ala Cys Gln Tyr
Ala Cys Tyr Gln
Ala Gln Cys Tyr
Ala Gln Tyr Cys
Ala Tyr Cys Gln
Ala Tyr Gln Cys
Cys Ala Gln Tyr
Cys Ala Tyr Gln
Cys Cys Cys Arg
Cys Cys Lys Met
Cys Cys Met Lys
Cys Cys Met Gln
Cys Cys Gln Met
Cys Cys Arg Cys
Cys Phe Asn Thr
Cys Phe Gln Ser
Cys Phe Ser Gln
Cys Phe Thr Asn
Cys His Pro Gln
Cys His Gln Pro
Cys Lys Cys Met
Cys Lys Met Cys
Cys Met Cys Lys
Cys Met Cys Gln
Cys Met Lys Cys
Cys Met Gln Cys
Cys Asn Phe Thr
Cys Asn Thr Phe
Cys Pro His Gln
Cys Pro Gln His
Cys Gln Ala Tyr
Cys Gln Cys Met
Cys Gln Phe Ser
Cys Gln His Pro
Cys Gln Met Cys
Cys Gln Pro His
Cys Gln Ser Phe
Cys Gln Tyr Ala
Cys Arg Cys Cys
Cys Ser Phe Gln
Cys Ser Gln Phe
Cys Thr Phe Asn
Cys Thr Asn Phe
Cys Tyr Ala Gln
Cys Tyr Gln Ala
Phe Cys Asn Thr
Phe Cys Gln Ser
Phe Cys Ser Gln
Phe Cys Thr Asn
Phe Asn Cys Thr
Phe Asn Thr Cys
Phe Gln Cys Ser
Phe Gln Ser Cys
Phe Ser Cys Gln
Phe Ser Gln Cys
Phe Thr Cys Asn
Phe Thr Asn Cys
Gly Met Asn Tyr
Gly Met Tyr Asn
Gly Asn Met Tyr
Gly Asn Tyr Met
Gly Tyr Met Asn
Gly Tyr Asn Met
His Cys Pro Gln
His Cys Gln Pro
His Pro Cys Gln
His Pro Gln Cys
His Gln Cys Pro
His Gln Pro Cys
Lys Cys Cys Met
Lys Cys Met Cys
Lys Met Cys Cys
Met Cys Cys Lys
Met Cys Cys Gln
Met Cys Lys Cys
Met Cys Gln Cys
Met Gly Asn Tyr
Met Gly Tyr Asn
Met Lys Cys Cys
Met Asn Gly Tyr
Met Asn Tyr Gly
Met Gln Cys Cys
Met Tyr Gly Asn
Met Tyr Asn Gly
Asn Cys Phe Thr
Asn Cys Thr Phe
Asn Phe Cys Thr
Asn Phe Thr Cys
Asn Gly Met Tyr
Asn Gly Tyr Met
Asn Met Gly Tyr
Asn Met Tyr Gly
Asn Thr Cys Phe
Asn Thr Phe Cys
Asn Tyr Gly Met
Asn Tyr Met Gly
Pro Cys His Gln
Pro Cys Gln His
Pro His Cys Gln
Pro His Gln Cys
Pro Gln Cys His
Pro Gln His Cys
Gln Ala Cys Tyr
Gln Ala Tyr Cys
Gln Cys Ala Tyr
Gln Cys Cys Met
Gln Cys Phe Ser
Gln Cys His Pro
Gln Cys Met Cys
Gln Cys Pro His
Gln Cys Ser Phe
Gln Cys Tyr Ala
Gln Phe Cys Ser
Gln Phe Ser Cys
Gln His Cys Pro
Gln His Pro Cys
Gln Met Cys Cys
Gln Pro Cys His
Gln Pro His Cys
Gln Ser Cys Phe
Gln Ser Phe Cys
Gln Tyr Ala Cys
Gln Tyr Cys Ala
Arg Cys Cys Cys
Ser Cys Phe Gln
Ser Cys Gln Phe
Ser Phe Cys Gln
Ser Phe Gln Cys
Ser Gln Cys Phe
Ser Gln Phe Cys
Thr Cys Phe Asn
Thr Cys Asn Phe
Thr Phe Cys Asn
Thr Phe Asn Cys
Thr Asn Cys Phe
Thr Asn Phe Cys
Tyr Ala Cys Gln
Tyr Ala Gln Cys
Tyr Cys Ala Gln
Tyr Cys Gln Ala
Tyr Gly Met Asn
Tyr Gly Asn Met
Tyr Met Gly Asn
Tyr Met Asn Gly
Tyr Asn Gly Met
Tyr Asn Met Gly
Tyr Gln Ala Cys
Tyr Gln Cys Ala
18-carboxy-19,20-dinor-N-acetyl-LTE4
6,7-Dimethoxy-4-{8-[(4-methyl-1-piperazinyl)sulfonyl]-3,4-dihydro -2(1H)-isoquinolinyl}quinazoline
Phenazinium,3-(diethylamino)-7-[2-(4-hydroxyphenyl)diazenyl]-5-phenyl-, chloride (1:1)
Avanafil
G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor
Amrubicin
A synthetic anthracycline antibiotic with molecular formula C25H25NO9. A specific inhibitor of topoisomerase II, it is used (particularly as the hydrochloride salt) in the treatment of cancer, especially lung cancer, where it is a prodrug for the active metabolite, ambrucinol. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents
N-[(1R,2R)-2-amino-1,2-diphenylethyl]-N-[3,5-bis(trifluoromethyl)phenyl]-Thiourea
5-Fluoro-N-(4-methyl-3-propionylaminosulfonylphenyl)-N-(4-(prop-2-ynyloxy)phenyl)-2,4-pyrimidinediamine
Cisapride monohydrate
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents
Baloxavir
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors
Piroxantrone hydrochloride
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents
Ethyl 4-[2-[1-[(2-methylphenyl)methyl]indol-3-yl]sulfonylacetyl]piperazine-1-carboxylate
N-Acetyl-L-phenylalanyl-4-[difluoro(phosphono)methyl]-L-phenylalaninamide
2-[3,6-bis(dimethylamino)-1H-xanthen-9-yl]-5-(2,5-dioxopyrrol-1-yl)benzoic acid
3-{6-[(8-Hydroxy-quinoline-2-carbonyl)-amino]-2-thiophen-2-YL-hexanoylamino}-4-oxo-butyri acid
(3Z,6S)-6-Chloro-1-(2-{[(5-chloro-1-benzothiophen-3-yl)methyl]amino}ethyl)-3-({2-[(2R)-2-piperidinyl]ethyl}imino)-2-piperazinol
Azlocillin sodium
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
(7Z)-7-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]-4-(3,4,5-trifluorophenyl)-1,3,4,8,9,9a-hexahydropyrido[2,1-c][1,4]oxazin-6-one
3-[(4-Phenyl-1-piperazinyl)sulfonyl]benzoic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester
N-(6-Methoxy-pyridazin-3-yl)-4-[3-(3-p-tolyl-acryloyl)-thioureido]-benzenesulfonamide
1-[4-(4-bromophenyl)-2-thiazolyl]-N-(3-phenylpropyl)-4-piperidinecarboxamide
N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[3-(4-fluorophenyl)-2,4-dioxo-1-thieno[3,2-d]pyrimidinyl]acetamide
1-(2,3-Dihydroindol-1-yl)-2-[[4-methyl-5-[4-(1-pyrrolidinylsulfonyl)phenyl]-1,2,4-triazol-3-yl]thio]ethanone
N-(9-ethyl-3-carbazolyl)-2-[5-(4-morpholinylsulfonyl)-2-thiophenyl]acetamide
3-acetamido-N-[4-(4-methylsulfonylphenyl)-2-thiazolyl]-3-phenyl-N-prop-2-enylpropanamide
4-[[3-[(2-chlorophenyl)methyl]-5-cyclopropyl-7-triazolo[4,5-d]pyrimidinyl]amino]-N,N-dimethylbenzenesulfonamide
1,9-Dimethyl-2,8-bis(2,4-dihydroxy-6-methylphenyl)-7-amino-3H-phenoxazine-3-imine
1-[(1R)-1-(benzenesulfonyl)-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
N-[2-[(2R,5S,6S)-5-[(3,4-dichlorophenyl)carbamoylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-4-fluorobenzamide
N-[2-[(2S,5S,6R)-5-[(3,4-dichlorophenyl)carbamoylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-4-fluorobenzamide
N-[2-[(2S,5R,6R)-5-[[(3,4-dichloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2R,5R,6R)-5-[[(3,4-dichloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2R,5R,6S)-5-[[(3,4-dichloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2S,5S,6S)-5-[(3,4-dichlorophenyl)carbamoylamino]-6-(hydroxymethyl)oxan-2-yl]ethyl]-4-fluorobenzamide
N-[2-[(2S,5R,6S)-5-[[(3,4-dichloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
1-(2,5-difluorophenyl)-3-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
1-(2,5-difluorophenyl)-3-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
1-(2,5-difluorophenyl)-3-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
2-fluoro-N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]ethyl]benzamide
2-fluoro-N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]ethyl]benzamide
2-fluoro-N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]ethyl]benzamide
N-[(2R,3S,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[(2S,3S,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[2-[(2R,5S,6R)-5-[[(3,4-dichloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
1-(2,5-difluorophenyl)-3-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
1-(2,5-difluorophenyl)-3-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
1-(2,5-difluorophenyl)-3-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
1-(2,5-difluorophenyl)-3-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
1-(2,5-difluorophenyl)-3-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(3-methylphenyl)sulfonylamino]-2-oxanyl]ethyl]urea
2-fluoro-N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]ethyl]benzamide
2-fluoro-N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]ethyl]benzamide
2-fluoro-N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]ethyl]benzamide
2-fluoro-N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]ethyl]benzamide
2-fluoro-N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]ethyl]benzamide
N-[(2R,3S,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[(2S,3S,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[(2R,3R,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[(2R,3R,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
[(1R)-1-(hydroxymethyl)-7-methoxy-2-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-phenylmethanone
1-[(1S)-1-(benzenesulfonyl)-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
5-bromo-3-pyridinecarboxylic acid [(6aS,9R,10aS)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6H-indolo[4,3-fg]quinoline-9-yl]methyl ester
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxy-2-methyl-3-oxo-1-phenylbutyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-hydroxy-2-methyl-3-oxo-1-phenylbutan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
4,7-DI(4-Ethoxyphenyl)-6-(4-methoxyphenyl)-1,2,5-thiadiazolo(3,4-C)pyridine
(Z)-N-[(4-Hydroxyphenyl)methyl]ethoxycarbothioamide 4-(tri-acetylrhamnoside)
Sermion
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
beta-aminoorceimine
A member of the class of phenoxazines that is 3-imino-1,9-dimethyl-3H-phenoxazine carrying an additional amino substituent at position 7 as well as two 2,4-dihydroxy-6-methylphenyl substituents at positions 2 and 8. The isomer in which the hydroxy groups at positions 2 and 2 on the phenyl rings are both on the same side of the plane of the phenoxazine ring system. A component of orcein, a mixture of dyes isolated from lichens.
gamma-aminoorceimine
A member of the class of phenoxazines that is 3-imino-1,9-dimethyl-3H-phenoxazine carrying an additional amino substituent at position 7 as well as two 2,4-dihydroxy-6-methylphenyl substituents at positions 2 and 8. The isomer in which the hydroxy groups at positions 2 and 2 on the phenyl rings are situated on opposite sides of the plane of the phenoxazine ring system. A component of orcein, a mixture of dyes isolated from lichens.
FTI-277 (hydrochloride)
FTI-277 hydrochloride is an inhibitor of farnesyl transferase (FTase); a highly potent Ras CAAX peptidomimetic which antagonizes both H- and K-Ras oncogenic signaling. FTI-277 hydrochloride can inhibit hepatitis delta virus (HDV) infection.